Clinical Advisors
Martin B. Leon, MD
Martin B. Leon is Chairman Emeritus of the Cardiovascular Research Foundation and Professor of Medicine at Columbia University Medical Center (CUMC). Dr. Leon also is the Associate Director of the Center for Interventional Vascular Therapy (CIVT) at CUMC and a practicing interventional cardiologist at New York-Presbyterian Hospital/CUMC. Dr. Leon has served as principal investigator for numerous clinical trials that have helped shape the field of interventional vascular medicine, including the STARS, Gamma-1, and (most recently) SIRIUS trial, which helped establish drug-eluting stents as the current standard of care for many cases of cardiovascular disease. Dr. Leon has co-authored over 900 publications, has performed over 7,000 interventional procedures, and has had a major impact on the development of modern interventional vascular devices and therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics, the largest dedicated meeting in interventional vascular therapy in the world.
Dr. Leon has been Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. He also served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.
He completed a fellowship in Cardiology at the Yale-New Haven Hospital. Dr. Leon completed medical school at the Yale School of Medicine, and his internship and residency in internal medicine at the Yale-New Haven Hospital.
Dr. Raoul Bonan, Institute of Cardiology, University of Montreal, Canada, Clinical Consultant
Dr.Raoul Bonan is a leading interventional cardiologist with particular experience in cardiological device development and clinical trials, has joined the Company as a Clinical Consultant. During his career, Dr. Bonan has helped develop and obtain FDA approval for several innovative interventional cardiac devices, including one of the first PTCA balloons, and others. Dr. Bonan has also held a number of executive and research roles in leading cardiac care and research institutions such as the Director of the Montreal Heart Institute, Chief of the Cardiac Catheterization Laboratory, and in a number of other posts at that institution. Dr. Bonan is an Associate Professor of Medicine at the University of Montreal, and Cardiologist Consultant at medical device developer CoreValve Inc., Conor , NMT Medical. He was also Vice President of Medical Affairs at Novoste Corporation. Dr. Bonan serves as Medical Advisor to many leading companies including Medtronic Vascular, providing strategic consultation relating to the delivery of therapeutic devices for the treatment of structural heart and vascular diseases. As Clinical Consultant Dr. Bonan oversee MIVT’s research and human clinical studies.
Alexandre Abizaid, MD, PhD
Alexandre Abizaid, MD, PhD is the Chief of Coronary Interventions at Institute Dante Pazzanese de Cardiologia in São Paulo, Brazil, and a Visiting Professor of Medicine at Columbia University Medical Center in New York City. He is also a key faculty member of CRF who spends part of his time in São Paulo leading an active research program, and in New York at CRF and Columbia, where he plays an important role as a co-director of TCT.
Dr Abizaid's areas of interest are drug-eluting stents and intravascular ultrasound. He has conducted several first-in-man studies testing multiple DES systems and participated very actively in numerous randomized trials and post-marketing registries. Dr Abizaid completed medical school at the Federal University of Juiz de Fora in Brazil, and his fellowship at Washington Hospital Center, in Washington, DC.
Daljeet Singh Gambhir, M.D., Director of Cardiology and Chief Executive Officer of the Kailash Heart Institute
Daljeet Singh Gambhir has been appointed to the Company's Medical Advisory Board and will hold the position of Clinical Advisor to MIVT India. In the position, Dr. Gambhir will oversee the next phases of MIVT's research and human clinical studies in India as the Company steps up development and commercialization of its novel, biocompatible cardiovascular stents. Dr. Gambhir has been an active cardiologist for nearly 25 years and is considered one of the most influential professionals in the field of interventional cardiology in India. Dr. Gambhir has been recognized as a pioneer of non-surgical interventional techniques and has performed nearly 10,000 coronary angioplasties in all types of lesions, vessels and clinical conditions. He also established the facility for Radiation Therapy for the treatment of coronary restenosis at G.B. Pant Hospital in New Delhi.
